Portal de investigación
Real-Life Effectiveness and Safety of Velpatasvir/Sofosbuvir/Voxilaprevir for Previously Daa Treated Patients with Chronic Hepatitis C
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Llaneras, J
- Barciela, MR
- Lens, S
- Baliellas, C
- Diago, M
- Garcia-Samaniego, FJ
- Arencibia, AC
- Arenas, J
- Gea, F
- Collell, XT
- Calleja, JL
- Carrion, JA
- Fernandez, I
- Morillas, R
- Zabal, JMR
- Carmona, I
- Fernandez-Rodriguez, CM
- Guerra, MNH
- Llerena, S
- Bernal, V
- Turnes, J
- Gonzalez, JM
- Montoliu, S
- Figueruela, B
- Badia, E
- Delgado, M
- Fernandez, M
- Inarrairaegui, M
- Pascasio, JM
- Rodriguez-Frias, F
- Esteban, R
- Buti, M
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Llaneras,J,Barciela,MR,Lens,S,Baliellas,C,Diago,M,Garcia,FJ,Arencibia,AC et al. Real-Life Effectiveness and Safety of Velpatasvir/Sofosbuvir/Voxilaprevir for Previously Daa Treated Patients with Chronic Hepatitis C. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting. 2018. San Francisco. TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103:LIPPINCOTT WILLIAMS & WILKINS. 2018 p.p. 405-406.